iBio Inc IBIO Q1 2026 Earnings EPS Miss on Higher RD Spend Stock Rises Despite No Revenue MRAM Q1 2026 Earnings EPS Beats Estimates by 19 Stock Edges Higher Investors Title Company Q4 2025 Earnings EPS of 397 Reported Stock Edges Lower GRAB Q1 2026 Earnings EPS Surges 8868 Above Estimates Stock Gains RSSS Q1 2026 Earnings EPS Falls Short Amidst 089 Stock Gain Solid Biosciences Q1 2026 Earnings WiderthanExpected Loss as Biotech Advances Pipeline